查詢結果分析
相關文獻
- Multimodality Treatment for Anal Cancer--A Case Report and Literature Review
- Microangiopathic Hemolytic Anemia in a Patient with Recurrent Anal Cancer and Liver Metastasis
- 固定深度治療對直腸肛門癌放射治療的影響
- Concurrent Chemotherapy and Radiotherapy of Anal Cancer
- 化學放射同步治療在子宮頸癌的應用
- 肛門癌器官保留治療方式
- 肛門癌之放射線及化學合併療法
- Primary Anal Cancer
- Treatment Outcomes for Epidermoid Carcinoma of the Anal Canal in a Single Institution
- 陰道癌之化學放射同步治療
頁籤選單縮合
題名 | Multimodality Treatment for Anal Cancer--A Case Report and Literature Review=多科整合治療肛門癌--病例報告及文獻回顧 |
---|---|
作者 | 黃麟傑; 劉美瑾; 簡哲民; | 書刊名 | 中華民國癌症醫學會雜誌 |
卷期 | 20:3 2004.09[民93.09] |
頁次 | 頁1-7 |
分類號 | 416.245 |
關鍵詞 | 肛門癌; 化學放射同步治療; Anal cancer; Chemoradiation; 5-fluorouracil; Mitomycin-C; |
語文 | 英文(English) |
中文摘要 | 化學放射同步治療用於侷限性肛門癌始於一九七○年代,我們報告一位四十二歲病人罹患局部侵犯性肛門扁平上皮細胞癌。我們給予原發腫瘤及骨盆腔合併雙側腹股溝放射治療共5040cGy。化學治療則為5-fluorouracil 1000mg/平方公尺,於放射治療之第一至四日及第二十九至三十二日連續輸注,另加mitomycin-C 10mg/平方公尺,於第一日靜脈注射。病人於治療結束後第六週之追蹤時已發現達到完全緩解,並且在接下來三十六個月的追蹤仍然維持在無病存活的狀態。 |
英文摘要 | Concurrent chemoradiation for locoreginal anal cancer has been prescribed since 1970's. We presented a 42-year-old male patient with locally advanced squamous cell carcinoma of anal canal. The radiation therapy was given at a dosage of 5,040 cGy to the primary tumor and the whole pelvis plus bilateral inguinal area. 5-fluorouracil was given by continuous infusion at a dosage of 1,000 mg/m^2 on days 1-4 of the radiation and repeated on days 29-32. Mitomycin-C was given as a bolus intravenous injection at a dosage of l0mg/m^2 on day 1. Complete remission was achieved 6 weeks after the chemoradiation finished, and the patient was still survived without recurrence at 36 months follow-up. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。